| Secondary |
| Hypertension |
26.5% |
| Coronary Artery Disease |
13.3% |
| Diabetes Mellitus |
8.8% |
| Chronic Obstructive Pulmonary Disease |
7.2% |
| Parkinson's Disease |
5.0% |
| Ulcer |
4.4% |
| Cardiac Failure |
3.9% |
| Pain |
3.3% |
| Angina Pectoris |
2.8% |
| Hyperuricaemia |
2.8% |
| Accidental Exposure |
2.2% |
| Arrhythmia |
2.2% |
| Benign Prostatic Hyperplasia |
2.2% |
| Bronchitis |
2.2% |
| Hypercholesterolaemia |
2.2% |
| Hypothyroidism |
2.2% |
| Nephrogenic Anaemia |
2.2% |
| Renal Failure |
2.2% |
| Sleep Disorder |
2.2% |
| Thrombosis |
2.2% |
|
| Angina Pectoris |
11.1% |
| Hypotension |
11.1% |
| Aortic Stenosis |
7.4% |
| Headache |
7.4% |
| Multi-organ Failure |
7.4% |
| Stevens-johnson Syndrome |
7.4% |
| Syncope |
7.4% |
| Accidental Exposure |
3.7% |
| Atrial Fibrillation |
3.7% |
| Blood Pressure Diastolic Decreased |
3.7% |
| Dyspnoea |
3.7% |
| Heart Rate Decreased |
3.7% |
| Intervertebral Disc Protrusion |
3.7% |
| Oedema |
3.7% |
| Pallor |
3.7% |
| Sepsis |
3.7% |
| Sinus Bradycardia |
3.7% |
| Somnolence |
3.7% |
|
| Concomitant |
| Hypertension |
26.0% |
| Product Used For Unknown Indication |
15.5% |
| Coronary Artery Disease |
12.8% |
| Pain |
5.5% |
| Atrial Fibrillation |
5.0% |
| Type 2 Diabetes Mellitus |
4.9% |
| Hiv Infection |
4.3% |
| Diabetes Mellitus |
3.9% |
| Rheumatoid Arthritis |
3.2% |
| Cardiac Failure |
2.2% |
| Drug Use For Unknown Indication |
2.1% |
| Prophylaxis |
2.0% |
| Hyperlipidaemia |
1.9% |
| Osteoporosis |
1.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
| Angina Pectoris |
1.7% |
| Metastatic Malignant Melanoma |
1.5% |
| Non-small Cell Lung Cancer |
1.4% |
| Back Pain |
1.2% |
| Nausea |
1.1% |
|
| Faecaloma |
8.6% |
| General Physical Health Deterioration |
8.6% |
| Syncope |
7.8% |
| Vomiting |
7.8% |
| Hyperglycaemia |
6.0% |
| Pericardial Haemorrhage |
6.0% |
| Dyspnoea |
5.2% |
| Neutropenia |
5.2% |
| Urinary Tract Infection |
5.2% |
| Angina Pectoris |
4.3% |
| Pseudomembranous Colitis |
4.3% |
| Renal Failure |
4.3% |
| Cholangitis Sclerosing |
3.4% |
| Dermatitis Allergic |
3.4% |
| Drug Interaction |
3.4% |
| Hypertensive Crisis |
3.4% |
| Loss Of Consciousness |
3.4% |
| Renal Failure Acute |
3.4% |
| Visual Impairment |
3.4% |
| Anxiety |
2.6% |
|
| Interacting |
|
| Hypotension |
50.0% |
| Syncope |
50.0% |
|
